CYGB and metastatic malignant neoplasm: Additionally, DcR3 was found to be negatively associated with HGB (P = 0.002, R = −0.59) and HCT (P = 0.001, R = −0.62) in subjects with non-metastatic cancers (Figure 3B, 3C).